A call for using natural compounds in the development of new antimalarial treatments-an introduction

被引:103
|
作者
Ginsburg, Hagai [1 ]
Deharo, Eric [2 ,3 ]
机构
[1] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
[2] Univ Toulouse, UPS, Lab Pharmacochim Subst Nat & Pharmacophores Redox, UMR 152, F-31062 Toulouse 9, France
[3] Inst Rech Dev, UMR 152, Lima, Peru
关键词
PLASMODIUM-FALCIPARUM; PLANTS; PRODUCTS; MEDICINES; SYNERGY; AGENTS; ETHNOPHARMACOLOGY; ARTEMISININ; COMBINATION; FLAVONOIDS;
D O I
10.1186/1475-2875-10-S1-S1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Natural compounds, mostly from plants, have been the mainstay of traditional medicine for thousands of years. They have also been the source of lead compounds for modern medicine, but the extent of mining of natural compounds for such leads decreased during the second half of the 20(th) century. The advantage of natural compounds for the development of drugs derives from their innate affinity for biological receptors. Natural compounds have provided the best anti-malarials known to date. Recent surveys have identified many extracts of various organisms (mostly plants) as having antiplasmodial activity. Huge libraries of fractionated natural compounds have been screened with impressive hit rates. Importantly, many cases are known where the crude biological extract is more efficient pharmacologically than the most active purified compound from this extract. This could be due to synergism with other compounds present in the extract, that as such have no pharmacological activity. Indeed, such compounds are best screened by cell-based assay where all potential targets in the cell are probed and possible synergies identified. Traditional medicine uses crude extracts. These have often been shown to provide many concoctions that deal better with the overall disease condition than with the causative agent itself. Traditional medicines are used by similar to 80 % of Africans as a first response to ailment. Many of the traditional medicines have demonstrable anti-plasmodial activities. It is suggested that rigorous evaluation of traditional medicines involving controlled clinical trials in parallel with agronomical development for more reproducible levels of active compounds could improve the availability of drugs at an acceptable cost and a source of income in malaria endemic countries.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] A call for using natural compounds in the development of new antimalarial treatments – an introduction
    Hagai Ginsburg
    Eric Deharo
    Malaria Journal, 10
  • [2] GOMPHOSTENIN AND GOMPHOCRITINE: NEW ANTIMALARIAL COMPOUNDS FROM THE NATURAL SOURCE
    Kaushik, M. P.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S21 - S22
  • [3] Development of antimalarial compounds with new mechanisms of action using next-generation synthesis
    Munoz, Benito
    Comer, Eamon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [4] Metalloporphyrins as a platform for the development of new antimalarial lead compounds.
    Wright, DW
    Ziegler, J
    Cole, KA
    Evans, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U261 - U261
  • [5] Search for New Antimalarial Compounds Obtained From Natural Sources by Molecular Modeling
    Leite, Franco Henrique A.
    Taranto, Alex G.
    Dos Santos Junior, Manoelito C.
    Branco, Alexsandro
    De Araujo, Martha T.
    Carneiro, Jose Walkimar De M.
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2010, 110 (11) : 2057 - 2066
  • [6] Towards development of new antimalarial compounds through in silico and in vitro assays
    Costa Junior, David Bacelar
    Lacerda, Pedro Sousa
    Varotti, Fernando de Pilla
    Leite, Fraco Henrique Andrade
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 111
  • [7] Development of a New Generation of 4-Aminoquinoline Antimalarial Compounds Using Predictive Pharmacokinetic and Toxicology Models
    Ray, Sunetra
    Madrid, Peter B.
    Catz, Paul
    LeValley, Susanna E.
    Furniss, Michael J.
    Rausch, Linda L.
    Guy, R. Kiplin
    DeRisi, Joseph L.
    Iyer, Lalitha V.
    Green, Carol E.
    Mirsalis, Jon C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (09) : 3685 - 3695
  • [8] Predicting new potential antimalarial compounds by using Zagreb topological indices
    Brito, Daniel
    Marquez, Edgar
    Rosas, Felix
    Rosas, Ennis
    AIP ADVANCES, 2022, 12 (04)
  • [9] Advances in clinical trial design for development of new TB treatments: A call for innovation
    Lienhardt, Christian
    Nahid, Payam
    PLOS MEDICINE, 2019, 16 (03)
  • [10] Discovery of New Potential Antimalarial Compounds Using Virtual Screening of ZINC Database
    Ghasemi, Jahan B.
    Shiri, Fereshteh
    Pirhadi, Somayeh
    Heidari, Zahra
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (02) : 227 - 234